首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets
Authors:Arrigo André-Patrick  Simon Stéphanie  Gibert Benjamin  Kretz-Remy Carole  Nivon Mathieu  Czekalla Anna  Guillet Dominique  Moulin Maryline  Diaz-Latoud Chantal  Vicart Patrick
Institution:Laboratoire Stress, Chaperons et Mort Cellulaire, CNRS, UMR5534, Centre de Génétique Moléculaire et Cellulaire, Université Lyon 1, Bat. Gregor Mendel, 16 Rue Dubois, F-69622, Villeurbanne Cedex, France. arrigo@univ-lyon1.fr
Abstract:Hsp27 and alphaB-crystallin are molecular chaperones that are constitutively expressed in several mammalian cells, particularly in pathological conditions. These proteins share functions as diverse as protection against toxicity mediated by aberrantly folded proteins or oxidative-inflammation conditions. In addition, these proteins share anti-apoptotic properties and are tumorigenic when expressed in cancer cells. This review summarizes the current knowledge about Hsp27 and alphaB-crystallin and the implications, either positive or deleterious, of these proteins in pathologies such as neurodegenerative diseases, myopathies, asthma, cataracts and cancers. Approaches towards therapeutic strategies aimed at modulating the expression and/or the activities of Hsp27 and alphaB-crystallin are presented.
Keywords:Hsp27  αB-crystallin  Neurodegenerative diseases  Myopathies  Cancers
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号